期刊文献+

马来酸依那普利联合阿替洛尔对慢性心力衰竭患者心功能及生活质量的影响 被引量:3

Effect of Enalapril Maleate Combined with Atenolol on Heart Function and Quality of Life in Patients with Chronic Heart Failure
下载PDF
导出
摘要 目的:探讨马来酸依那普利结合阿替洛尔治疗慢性心力衰竭的临床治疗效果。方法:将2014年1月~2017年5月收治的94例慢性心力衰竭患者随机分为两组(n=47),参照组采用常规治疗,试验组采用马来酸依那普利联合阿替洛尔治疗,比较两组患者的疗效差异。结果:两组患者治疗前的SBP、DBP、LVEF、LVESD、LVEDD及治疗后的SBP、DBP指标对比差异不明显(P>0.05),但上述观察指标与治疗前对比差异明显,且试验组的心功能指标与生活质量评分显著优于参照组,组间数据对比差异有统计学意义(P<0.05)。结论:马来酸依那普利结合阿替洛尔治疗慢性心力衰竭,既可以降低血压,改善患者的心功能,又有助于提升患者的生活质量,因而适合用于临床推广。 Objective: To investigate the clinical effect of enalapril maleate combined with atenolol in the treatment of chronic heart failure. Methods: 94 cases of chronic heart failure patients admitted from January 2014 to May 2017 were randomly divided into two groups ( n =47), control group used conventional treatment, experimental group was treated with enalapril maleate combined with atenolol treatment, compared the differences of efficacy of the two groups. Results: There was no significant difference in SBP, DBP, LVEF, LVESD, LVEDD between the two groups before treatment and SBP and DBP after treatment( P 〉 0.05 ),however, the above observation indexes were significantly different from those before treatment.In addition, the cardiac function index and quality of life score of the experimental group were significantly better than that of the control group,the difference was statistically significant( P 〈0.05). Conclusion: Enalapril maleate combined with atenolol in the treatment of chronic heart failure can reduce blood pressure, improve heart function of patients, and help to improve the quality of life of patients, thus it is suitable for clinical promotion.
作者 麻文强 Ma Wenqiang(Department of General Internal Medicine,Yichuan County People's Hospital,Luoyang 471300)
出处 《数理医药学杂志》 2018年第10期1535-1536,共2页 Journal of Mathematical Medicine
关键词 慢性心力衰竭 马来酸依那普利 阿替洛尔 心功能 生活质量 chronic heart failure enalapril maleate atenolol cardiac function quality of life
  • 相关文献

二级参考文献56

  • 1中华人民共和国卫生部.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002.115-119.
  • 2Fortini C,Toffoletto B,Fucili A,et al.Circulating stem cell vary with NYHA stage in heart failure patients[J].J Cell Mol Med,2011,15(8):1 726.
  • 3无.慢性心力衰竭诊断治疗指南[J].中华心血管病杂志,2007,35(12):1076-1095. 被引量:3698
  • 4Alehagen U, Dahlstr~m U, Rehfeld JF, et al. Association of copeptin and N-terminal proBNP concentration with risk of cardiovascular death in older patients with symptoms of heart failure [J]. JAMA, 2011, 305 (20):2088-2095.
  • 5Funck - Brentano C,Veldhuisen DJV,Ven LLMVD,et al. Influe-nce of order and type of drug (bisoprolol vs. enalapril) on outcomeand adverse events in patients with chronic heart failure: a posthoc,analysis of the CIBIS - III trial [J]. European Journal of HeartFailure ,2011,13(7):765 -772.
  • 6Kang YM, Zhang DM, Yu XJ, et al. Chronic infusion of enalaprilatinto hypothalamic paraventricular nucleus attenuates angiotensinII- induced hypertension and cardiac hypertrophy by restoringneurotransmitters and cytokines [J] . Toxicology & Applied Phar-macology ,2014,274(3): 436 - 444.
  • 7Hawwa N, Schreiber Jr MJ, Tang WHW. Pharmacologic Manage-ment of Chronic Reno - Cardiac Syndrome [J] . Current HeartFailure Reports,2013 ,10( 1): 54 - 62.
  • 8Sun JZ, Cao LH, Liu H. ACE inhibitors in cardiacsurgery: current studies and controversies [J]. Hypertension Re-search Official Journal of the Japanese Society of Hypertension,2011,34(1): 15 -22.
  • 9Kim NY,Yoo YC, Chun DH, et al. The Effects of Oral Atenolol orEnalapril Premedication on Blood Loss and Hypotensive Anes-thesia in Orthognathic Surgery. [J] . Yonsei Medical Journal,2015,56(4): 1 114-1 121.
  • 10陈琦玲,王鸿懿,孙宁玲.血浆同型半胱氨酸与冠心病及高血压的相关性研究[J].中华老年心脑血管病杂志,2010,12(3):233-235. 被引量:31

共引文献84

同被引文献15

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部